Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 626.12% and ...

Eli Lilly has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self-pay for adults ...

Analyst Akash Tewari of Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), boosting the price target to ...

Eli Lilly is acquisitive, too, and just purchased a company called Morphic Holding. The acquisition expands the healthcare ...

The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the ...

Cybersecurity expert Sonali Shah takes the helm at Cobalt to drive innovation and growth in the Pentest as a Service sector, ...

The launch of a single-use vial form of the popular weight loss medicine could help Lilly improve supply and compete with telehealth companies offering compounded versions.

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Morphic Holding, Inc. (NASDAQ: MORF). Morphic is a biopharmaceutical company developing oral ...

Meta, Costco and Eli Lilly along with two others are trading near buy points coming out of a week marked by Nvidia earnings.

Shares of biotech firm Morphic Holding, founded by Harvard immunologist Tim Springer, rocketed up 75% Monday after Eli Lilly said it would snap it up for $3.2 billion.